Nuveen Fund Advisors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,275
Closed -$423K 21
2018
Q4
$423K Sell
3,275
-2,260
-41% -$315K 3.75% 3
2018
Q3
$765K Sell
5,535
-2,805
-34% -$373K 1.7% 12
2018
Q2
$1.01M Sell
8,340
-4,018
-33% -$501K 1.25% 12
2018
Q1
$1.58M Sell
12,358
-4,513
-27% -$610K 0.73% 36
2017
Q4
$2.36M Sell
16,871
-7,938
-32% -$1.11M 0.68% 36
2017
Q3
$3.23M Sell
24,809
-7,272
-23% -$964K 0.66% 41
2017
Q2
$4.24M Sell
32,081
-3,233
-9% -$412K 0.68% 39
2017
Q1
$4.4M Buy
35,314
+2,050
+6% +$245K 0.58% 38
2016
Q4
$3.83M Sell
33,264
-1,908
-5% -$220K 0.55% 45
2016
Q3
$4.16M Buy
35,172
+359
+1% +$43.6K 0.58% 44
2016
Q2
$4.22M Buy
+34,813
New +$3.96M 0.65% 38

Other funds holding JNJ

Nuveen Fund Advisors's JNJ Position: Q1 2019 in Review

Nuveen Fund Advisors sold out of Johnson & Johnson (JNJ) in Q1 2019, closing a stake of 3,275 shares — an estimated $423K sold.

Nuveen Fund Advisors first reported a position in JNJ in Q2 2016 and held it in 11 quarters. The position peaked at $4.4M in Q1 2017. 2,765 funds tracked by Wall St. Rank hold JNJ as of Q1 2019.

  • Nuveen Fund Advisors reported no remaining Johnson & Johnson position as of Q1 2019 after selling out during the quarter.
  • Nuveen Fund Advisors sold 3,275 Johnson & Johnson shares in Q1 2019, an estimated $423K.
  • Nuveen Fund Advisors first reported a position in Johnson & Johnson in Q2 2016 and held it in 11 quarters.
  • Nuveen Fund Advisors's Johnson & Johnson position peaked at $4.4M in Q1 2017.
  • 2,765 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2019.

Based on Nuveen Fund Advisors's 13F filing for Q1 2019, filed 14 May 2019.